Xencor
465 North Halstead Street, Suite 200
Pasadena
California
91107
United States
Tel: 626-305-5900
Website: http://www.xencor.com/
332 articles about Xencor
-
Xencor To Host Fourth Quarter And Full Year 2016 Financial Results Webcast And Conference Call On February 28, 2017
2/22/2017
-
Xencor Release: Igg4-Related Disease Biomarker Development Update Presented From An Ongoing, Open-Label, Phase II Study Of Xmab5871 In Igg4-RD At The 3rd International Symposium On Igg4-Related Diseases & Fibrosis
2/20/2017
-
Xencor Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Option To Purchase Additional Shares Of Common Stock
12/7/2016
-
Xencor Prices Public Offering Of Common Stock
12/1/2016
-
Xencor Announces Proposed Public Offering Of Common Stock
12/1/2016
-
Xencor Reports Third Quarter 2016 Financial Results
11/3/2016
-
Why Biogen, bluebird bio and Xencor are 3 Stocks to Look at in November
11/3/2016
-
Selexis SA And Xencor Enter Strategic Agreement, Strengthening Existing Relationship For Multi-Specific Antibody Cell Line Development
11/3/2016
-
Selexis SA And Xencor Enter Strategic Agreement, Strengthening Existing Relationship For Multi-Specific Antibody Cell Line Development
11/3/2016
-
Xencor Release: Xenoscope, the Revolutionary Cost-effective Laparoscope, Wins FDA Fast Track Clearance
10/4/2016
-
Xencor Release: Preliminary Data From The Ongoing Open-Label Xmab5871 Phase 2 Pilot Study In Igg4-Related Disease To Be Presented At American College of Rheumatology 2016 Annual Meeting
10/3/2016
-
Xencor Grows In San Diego
9/28/2016
-
Xencor Initiates Phase 1b Trial Of Subcutaneous Formulation Of Xmab7195
9/15/2016
-
Xencor Doses First Patient In Lead Immuno-Oncology Bispecific Program Xmab14045 For The Treatment Of Acute Myeloid Leukemia And Other CD123-Expressing Hematologic Malignancies
9/12/2016
-
Xencor To Present At Upcoming Investor Conferences
8/31/2016
-
Xencor To Present At Upcoming Investor Conferences
8/3/2016
-
Xencor Reports Second Quarter 2016 Financial Results
8/3/2016
-
Xencor To Host Second Quarter 2016 Financial Results Webcast And Conference Call On August 2, 2016
7/26/2016
-
Xencor Provides Updates On Lead Programs And Reviews Bispecific Oncology Partnership; Announces Expansion Of Bispecific Oncology Pipeline At Analyst Day
6/28/2016
-
Novartis AG Taps Xencor's Bispecifics Expertise in $150 Million Immuno-Oncology Deal
6/28/2016